TrialJournal of cancer research and clinical oncology2023

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer.

Katrin M Sjoquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.